Featured Research

from universities, journals, and other organizations

Ultrathin collagen matrix biomaterial tool for 3-D microtissue engineering

Date:
April 3, 2014
Source:
World Scientific
Summary:
A novel ultrathin collagen matrix assembly allows for the unprecedented maintenance of liver cell morphology and function in a microscale 'organ-on-a-chip' device that is one example of 3D microtissue engineering. This technology allows researchers to provide cells with the precise extracellular matrix cues that they require to maintain their differentiated form and liverspecific functions, including albumin and urea production.

An ultrathin collagen matrix assembly maintained the morphology and function of primary liver hepatocytes in a microfluidic organ-on-a-chip device for two weeks. Three images of the hepatocytes after two weeks in a microfluidic device: A phase contrast image of cell morphology at two weeks showing dense cyto-plasm, distinct nuclei, and bright cell borders; bile canalicular network develop-ment (red); and cell nuclei (blue) and actin (green) organization demonstrating cell polarity. Scale bar: 50 microns.
Credit: William McCarty, the Center for Engineering in Medicine at the Massachusetts General Hospital, Harvard Medi-cal School, and the Shriners Hospitals for Children-Boston

A novel ultrathin collagen matrix assembly allows for the unprecedented maintenance of liver cell morphology and function in a microscale "organ-on-a-chip" device that is one example of 3-D microtissue engineering.

Related Articles


A team of researchers from the Center for Engineering in Medicine at the Massachusetts General Hospital have demonstrated a new nanoscale matrix biomaterial assembly that can maintain liver cell morphology and function in microfluidic devices for longer times than has been previously been reported in microfluidic devices. This technology allows researchers to provide cells with the precise extracellular matrix cues that they require to maintain their differentiated form and liverspecific functions, including albumin and urea production. The novel technique reported offers a new tool for basic science and pre-clinical investigations, and allows for the creation of stable liver microtissues for use in organ-on-a-chip devices to mimic healthy liver physiology, investigate liver diseases, and test the toxicity of potential therapeutic drugs before using animals or clinical studies. This report appears in the current issue of the journal Technology.

"This is a clever combination of the well-known layer-by-layer deposition technique for creating thin matrix assemblies and collagen functionalization chemistries that will really enable complex liver microtissue engineering by replicating the physiological cues that maintain the state of liver cell differentiation," says Martin Yarmush, M.D., Ph.D., of the Massachusetts General Hospital and senior author on this paper. "The ultrathin collagen matrix biomaterial and its ability to keep liver cells functional for longer periods of time in chip devices will undoubtedly be a useful tool for creating liver microtissues that mimic the true physiology of the liver, including cell and matrix spatial geometries." By creating polyanionic and polycationic solutions of collagen, a ubiquitous extracellular matrix molecule, and alternately exposing liver cells seeded in microfluidic devices to the solutions, the investigators were able to create a nanoscale assembly of collagen on top of the cells. This process can be used to form biologically relevant coatings on many types of charged surfaces to direct cell alignment, increase attachment efficiency, and maintain morphology and function.

"This technique is a nice example of how the translation of established methods for cell culture into microfluidic devices can produce new tools for understanding biological systems, such as cell-matrix interactions," says William McCarty, Ph.D., the lead author on this paper. The team from the Massachusetts General Hospital plans to use this technology in a variety of engineering applications, including constructing liver microtissues by layering together the different types of cells that make up the liver. The liver plays a central role in human-drug interactions and is a common target for drug-induced toxicity, which can result in costly, late-stage and post-approval drug failures when animal models fail to predict human toxicity reactions. To address the current lack of predictive in vitro tools, the investigators are developing scalable liver micro-tissues that could be used to better understand the toxic effects of drugs, as well as provide a high throughput system for testing drug-drug interactions.


Story Source:

The above story is based on materials provided by World Scientific. Note: Materials may be edited for content and length.


Journal Reference:

  1. C.S. Tsai, R.W. Mao, S.K. Lin, Y. Zhu, S.C. Tsai. Faraday instability-based micro droplet ejection for inhalation drug delivery. TECHNOLOGY, 2014; 02 (01): 75 DOI: 10.1142/S233954781450006X

Cite This Page:

World Scientific. "Ultrathin collagen matrix biomaterial tool for 3-D microtissue engineering." ScienceDaily. ScienceDaily, 3 April 2014. <www.sciencedaily.com/releases/2014/04/140403095407.htm>.
World Scientific. (2014, April 3). Ultrathin collagen matrix biomaterial tool for 3-D microtissue engineering. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2014/04/140403095407.htm
World Scientific. "Ultrathin collagen matrix biomaterial tool for 3-D microtissue engineering." ScienceDaily. www.sciencedaily.com/releases/2014/04/140403095407.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) — Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) — AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) — Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins